Crystal structures of complexes between the R61 DD-peptidase and peptidoglycan-mimetic beta-lactams: a non-covalent complex with a "perfect penicillin".

The bacterial D-alanyl-D-alanine transpeptidases (DD-peptidases) are the killing targets of beta-lactams, the most important clinical defense against bacterial infections. However, due to the constant development of antibiotic-resistance mechanisms by bacteria, there is an ever-present need for new, more effective antimicrobial drugs. While enormous numbers of beta-lactam compounds have been tested for antibiotic activity in over 50 years of research, the success of a beta-lactam structure in terms of antibiotic activity remains unpredictable. Tipper and Strominger suggested long ago that beta-lactams inhibit DD-peptidases because they mimic the D-alanyl-D-alanine motif of the peptidoglycan substrate of these enzymes. They also predicted that beta-lactams having a peptidoglycan-mimetic side-chain might be better antibiotics than their non-specific counterparts, but decades of research have not provided any evidence for this. We have recently described two such novel beta-lactams. The first is a penicillin having the glycyl-L-alpha-amino-epsilon-pimelyl side-chain of Streptomyces strain R61 peptidoglycan, making it the "perfect penicillin" for this organism. The other is a cephalosporin with the same side-chain. Here, we describe the X-ray crystal structures of the perfect penicillin in non-covalent and covalent complexes with the Streptomyces R61 DD-peptidase. The structure of the non-covalent enzyme-inhibitor complex is the first such complex to be trapped crystallographically with a DD-peptidase. In addition, the covalent complex of the peptidyl-cephalosporin with the R61 DD-peptidase is described. Finally, two covalent complexes with the traditional beta-lactams benzylpenicillin and cephalosporin C were determined for comparison with the peptidyl beta-lactams. These structures, together with relevant kinetics data, support Tipper and Strominger's assertion that peptidoglycan-mimetic side-chains should improve beta-lactams as inhibitors of DD-peptidases.

[1]  J. Frère,et al.  Use of model enzymes in the determination of the mode of action of penicillins and delta 3-cephalosporins. , 1979, Annual review of biochemistry.

[2]  G. Sheldrick,et al.  SHELXL: high-resolution refinement. , 1997, Methods in enzymology.

[3]  N. Georgopapadakou,et al.  Probing the binding site of the penicillin side-chain based on the tipper-Strominger hypothesis , 1993 .

[4]  V. Luzzati,et al.  Traitement statistique des erreurs dans la determination des structures cristallines , 1952 .

[5]  J. Frère,et al.  Bacterial DD-transpeptidases and penicillin. , 1995, Essays in biochemistry.

[6]  J. Anderson,et al.  Dipeptide binding to the extended active site of the Streptomyces R61 D-alanyl-D-alanine-peptidase: the path to a specific substrate. , 2000, Biochemistry.

[7]  I. Massova,et al.  Kinship and Diversification of Bacterial Penicillin-Binding Proteins and β-Lactamases , 1998, Antimicrobial Agents and Chemotherapy.

[8]  P. Kraulis.  A program to produce both detailed and schematic plots of protein structures , 1991 .

[9]  R. Pratt,et al.  The perfect penicillin? Inhibition of a bacterial DD-peptidase by peptidoglycan-mimetic beta-lactams. , 2004, Journal of the American Chemical Society.

[10]  E A Merritt,et al.  Expanding the model: anisotropic displacement parameters in protein structure refinement. , 1999, Acta crystallographica. Section D, Biological crystallography.

[11]  N. Cohen.  β-LACTAM ANTIBIOTICS: GEOMETRICAL REQUIREMENTS FOR ANTIBACTERIAL ACTIVITIES , 1983 .

[12]  D J Tipper,et al.  Mechanism of action of penicillins: a proposal based on their structural similarity to acyl-D-alanyl-D-alanine. , 1965, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Frère,et al.  A new kinetic mechanism for the concomitant hydrolysis and transfer reactions catalyzed by bacterial DD-peptidases. , 1993, Biochemistry.

[14]  J. Frère,et al.  Penicillin-sensitive enzymes in peptidoglycan biosynthesis. , 1985, Critical reviews in microbiology.

[15]  M. Nardelli,et al.  Is the conformation of the thiazolidine ring of penicillins of any importance for their antibacterial activity , 1980 .

[16]  N. Silvaggi,et al.  The crystal structure of phosphonate-inhibited D-Ala-D-Ala peptidase reveals an analogue of a tetrahedral transition state. , 2003, Biochemistry.

[17]  B. Lee,et al.  Conformation of penicillin as a transition-state analog of the substrate of peptidoglycan transpeptidase. , 1971, Journal of molecular biology.

[18]  J. Frère,et al.  Structure-activity relationships in the beta-lactam family: an impossible dream. , 1988, Biochemical pharmacology.

[19]  J. Strominger,et al.  Penicillin-binding proteins and the mechanism of action of beta-lactam antibiotics. , 1983, Annual review of biochemistry.

[20]  N. Cohen.  beta-Lactam antibiotics: geometrical requirements for antibacterial activities. , 1983, Journal of medicinal chemistry.

[21]  J. E. Dolfini,et al.  6-methyl penicillins and 7-methyl cephalosporins. , 1971, Journal of the American Chemical Society.

[22]  J. Frère,et al.  Crystallographic mapping of beta-lactams bound to a D-alanyl-D-alanine peptidase target enzyme. , 1989, Journal of molecular biology.

[23]  B K Shoichet,et al.  Structures of ceftazidime and its transition-state analogue in complex with AmpC beta-lactamase: implications for resistance mutations and inhibitor design. , 2001, Biochemistry.

[24]  B. Shoichet,et al.  Crystal Structures of Substrate and Inhibitor Complexes with AmpC β-Lactamase: Possible Implications for Substrate-Assisted Catalysis , 2000 .

[25]  D J Tipper,et al.  Mode of action of beta-lactam antibiotics. , 1985, Pharmacology & therapeutics.

[26]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[27]  D. Pruess,et al.  Antibacterial properties of (2,3)-alpha- and (2,3)-beta-methylene analogs of penicillin G , 1988, Antimicrobial Agents and Chemotherapy.

[28]  N. Silvaggi,et al.  Structures of two kinetic intermediates reveal species specificity of penicillin-binding proteins. , 2002, Journal of molecular biology.

[29]  A. Kuzin,et al.  Binding of cephalothin and cefotaxime to D-ala-D-ala-peptidase reveals a functional basis of a natural mutation in a low-affinity penicillin-binding protein and in extended-spectrum beta-lactamases. , 1995, Biochemistry.

[30]  D E McRee,et al.  XtalView/Xfit--A versatile program for manipulating atomic coordinates and electron density. , 1999, Journal of structural biology.

[31]  A. L. Koch.  Penicillin Binding Proteins, β-Lactams, and Lactamases: Offensives, Attacks, and Defensive Countermeasures , 2000, Critical reviews in microbiology.

[32]  R. Pratt,et al.  Functional evolution of the serine β-lactamase active site , 2002 .

[33]  D B Boyd,et al.  Transition state structures of a dipeptide related to the mode of action of beta-lactam antibiotics. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Samy O Meroueh,et al.  Structural aspects for evolution of beta-lactamases from penicillin-binding proteins. , 2003, Journal of the American Chemical Society.

[35]  Bernstein Nj,et al.  On the importance of a methyl group in beta-lactamase evolution: free energy profiles and molecular modeling. , 1999 .

[36]  R. Pratt,et al.  Kinetic and structural consequences of the leaving group in substrates of a class C β-lactamase , 2004 .

[37]  J. Strominger,et al.  Bacterial cell wall synthesis and structure in relation to the mechanism of action of penicillins and other antibacterial agents. , 1965, The American journal of medicine.

[38]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.